MacEwan J - Search Results

1

Modeling the impact of patient treatment preference on health outcomes in relapsing-remitting multiple sclerosis.

van Eijndhoven E, Brauer M, Kee R, MacEwan J, Mucha L, Wong SL, Durand A, Shafrin J. van Eijndhoven E, et al. Among authors: macewan j. J Med Econ. 2020 May;23(5):474-483. doi: 10.1080/13696998.2019.1711100. Epub 2020 Jan 21. J Med Econ. 2020. PMID: 31903813 Free article.

2

Physician and Patient Preferences for Nonvalvular Atrial Fibrillation Therapies.

Shafrin J, Bruno A, MacEwan JP, Campinha-Bacote A, Trocio J, Shah M, Tan W, Romley JA. Shafrin J, et al. Among authors: macewan jp. Value Health. 2016 Jun;19(4):451-9. doi: 10.1016/j.jval.2016.01.001. Epub 2016 Mar 2. Value Health. 2016. PMID: 27325337 Free article.

3

Pharmaceutical Innovation in the Treatment of Schizophrenia and Mental Disorders Compared with Other Diseases.

MacEwan JP, Seabury S, Aigbogun MS, Kamat S, van Eijndhoven E, Francois C, Henderson C, Citrome L. MacEwan JP, et al. Innov Clin Neurosci. 2016 Aug 1;13(7-8):17-25. eCollection 2016 Jul-Aug. Innov Clin Neurosci. 2016. PMID: 27672484 Free PMC article.

4

Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia.

MacEwan JP, Forma FM, Shafrin J, Hatch A, Lakdawalla DN, Lindenmayer JP. MacEwan JP, et al. J Manag Care Spec Pharm. 2016 Nov;22(11):1349-1361. doi: 10.18553/jmcp.2016.22.11.1349. J Manag Care Spec Pharm. 2016. PMID: 27783548 Free PMC article.

5

Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators.

Jansen JP, Incerti D, Mutebi A, Peneva D, MacEwan JP, Stolshek B, Kaur P, Gharaibeh M, Strand V. Jansen JP, et al. J Med Econ. 2017 Jul;20(7):703-714. doi: 10.1080/13696998.2017.1307205. Epub 2017 Apr 5. J Med Econ. 2017. PMID: 28294642 Free article.

6

The importance of model inputs and assumptions in conducting health technology assessments of novel drugs.

Philipson T, MacEwan JP. Philipson T, et al. J Med Econ. 2017 Oct;20(10):1107-1109. doi: 10.1080/13696998.2017.1359182. Epub 2017 Aug 4. J Med Econ. 2017. PMID: 28737052 Free article. No abstract available.

7

Medication Adherence Patterns Among Patients with Multiple Serious Mental and Physical Illnesses.

MacEwan JP, Silverstein AR, Shafrin J, Lakdawalla DN, Hatch A, Forma FM. MacEwan JP, et al. Adv Ther. 2018 May;35(5):671-685. doi: 10.1007/s12325-018-0700-6. Epub 2018 May 3. Adv Ther. 2018. PMID: 29725982 Free PMC article.

8

Using Information on Patient Adherence to Antipsychotic Medication to Understand Their Adherence to Other Medications.

Shafrin J, Silverstein AR, MacEwan JP, Lakdawalla DN, Hatch A, Forma FM. Shafrin J, et al. Among authors: macewan jp. P T. 2019 Jun;44(6):350-357. P T. 2019. PMID: 31160870 Free PMC article.

9

Changes in mortality associated with cancer drug approvals in the United States from 2000 to 2016.

MacEwan JP, Dennen S, Kee R, Ali F, Shafrin J, Batt K. MacEwan JP, et al. J Med Econ. 2020 Dec;23(12):1558-1569. doi: 10.1080/13696998.2020.1834403. Epub 2020 Nov 9. J Med Econ. 2020. PMID: 33161782 Free article.

10

The Value of Survival Gains in Pancreatic Cancer from Novel Treatment Regimens.

MacEwan JP, Yin W, Kaura S, Khan ZM. MacEwan JP, et al. J Manag Care Spec Pharm. 2017 Feb;23(2):206-213. doi: 10.18553/jmcp.2017.23.2.206. J Manag Care Spec Pharm. 2017. PMID: 28125374 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters